Having established that JAM-C blockade led to a greater reduction in plaque CD68+ cells in our mouse model of atherosclerosis regression, we investigated the distribution of JAM-C within the atherosclerotic plaques. This evidence concerns the gene JAM3 and atherosclerosis.